Week beginning 23rd June 2024
News, advocacy and articles
Australia National Health and Medical Research Council
Members of the NHMRC ME/CFS Guideline Development Committee have been announced.
Announcement |
Thread
Trial by Error by David Tuller
Dutch Journalist Faces Off Against CBT/GET Ideologues
The Dutch health journalist Sander Zurhake is the reporter behind a package of stories on the harms of psycho-behavioural treatments for children with ME/CFS. This resulted in harsh criticism from the Dutch Association for Pediatrics and the Association for Behavioural and Cognitive Therapies but then got supported by more than 100 doctors, psychologists and other health care providers in an open letter. Tuller comments: "When journalists and media organizations go up against powerful medical interests, it is critical that they are able to back everything up. Zurhake has done his homework here. To anyone following the exchange, he clearly has the winning hand."
Article l
Thread
An interview with Sjoerd Beentjes, Lead Author of Big Data Study on "Blood-Based Biomakers" for ME/CFS
A video interview with lead author of the paper "Replicated blood-based biomarkers for Myalgic Encephalomyelitis not explicable by inactivity". Duration: 18 minutes.
Interview l
Thread
Emerge Australia SBS Insight Invisible Illness – Statement By 4 Studio Participants
Emerge has published a statement criticising the recent broadcast as being in breach of its journalistic code of ethics. "We are united in our deep concern over how the episode was produced, edited, and presented and the serious harm it caused by misrepresenting Myalgic Encephalomyelitis (ME/CFS) and its impact on the wider chronic illness community."
Statement |
Thread
...........
Research news and commentary
Conference talks from the ME/CFS and Long Covid conference Digging Deeper which took place in Stavanger, Norway last month are now available on YouTube. Speakers are: Kristian Sommerfelt, Carmen Scheibenbogen, Øystein Fluge, Karl Johan Tronstad, David Putrino, David Systrom, Rob Wüst, Trude Schei, Brian Hughes, Anniken Aase Sommerfelt and Michelle Bull. Talks in Norwegian have English subtitles. Organiser: the Norwegian ME Association - Rogaland.
YouTube channel l
Thread
Solve ME has selected the Simmaron Research Institute as the winner of their second Solve ME/CFS Catalyst Award for its study, “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions.”
Article |
Thread
Solve ME has awarded more funding to
Ramsay grant awardees Dr. Geraldine Cambridge and Dr. Dana Yelin. Dr. Cambridge won over $80,000 from ME Research UK to determine how antibody patterns predict ME/CFS–symptom severity. Dr Yelin's project is "Enhanced External Counterpulsation (EECP), Non-invasive Approach to Treat Long Covid Fatigue."
Article |
Thread
UK Action for ME The recording from the Genetics Centre of Excellence webinar on 6 June is now available. "Presentations from Audrey Ryback, Research Fellow at the University of Edinburgh (funded by Action for ME), and PrecisionLife, our Partners in the LOCOME research project." Duration 1 hour.
Video |
Thread
Australia Announcement of the OUTPOST Study
"A landmark study led by the University of Melbourne, the Doherty Institute, the Kirby Institute at UNSW Sydney and the University of Adelaide aims to understand how common these persistent illnesses are and use this information to inform clinical practice and improve health and wellbeing."
Announcement |
Study Link |
Thread
..........
Coming Events:
Bateman Horne Center - Free Online Support Group
Tuesday, July 8, 1:00 - 2:00 PM Mountain Time
Topic: To Be Announced
Advance registration required, see thread for times in your time zone.
Details |
Thread
Solve ME Webinar - The ADDRESS-LC Trial: Studying the Impact of Bezisterim on Brain fog and Fatigue in People with Long Covid
Solve CEO Emily Taylor and a group of panelists will discuss the latest updates on Long COVID research and the ADDRESS-LC trial.
Tuesday, July 22, 3 PM Pacific / 6 PM Eastern
Details |
Registration |
Thread
Solve ME Webinar - Probing Functional Autoantibodies in Patients with ME/CFS
Dr. Akiko Iwasaki and Solve CEO Emily Taylor will discuss the research.
Thursday, July 31, 12 PM Pacific / 3 PM Eastern
Details |
Registration |
Thread
.................
Research
ME/CFS research
Frontiers in Immunology
Amplification of select autonomous HERV loci and surrounding host gene transcription in monocytes from patients with post-acute sequelae of COVID-19 — Koo and Morrow
"positive HERV were detected in all patients from a scRNA-seq analysis of samples taken 8 months post-acute COVID-19, with 3 specific HERV loci positive across all 12 patients"
Article |
Thread
International Journal of Molecular Sciences
Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME/CFS and Long COVID — Li, Kalafatis, Xiao et al.
"Utilizing genome-wide metabolic modeling, we identified key metabolic irregularities in the muscle of patients with ME/CFS, notably the downregulation of the alanine and aspartate metabolism pathway and the arginine and proline metabolism pathway."
Article |
Thread
Autoimmunity Reviews
Advancing research on regulatory autoantibodies targeting GPCRs: Insights from the 5th international symposium — Cabral-Marques et al.
"The symposium highlighted their involvement in multiple prominent pathologies, including autoimmune diseases, cardio- and cerebrovascular diseases, and neuroimmunologic disorders such as myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 syndrome"
Article |
Thread
Frontiers in Health Services
Assessing the influence of lived-experience experts on healthcare providers in a virtual community of practice: a qualitative study — Weaver, Unger et al.
"By including people with lived-experience of Long COVID, ME/CFS, and other PAIS as subject matter experts for LC&FIRP medical education activities, we aimed to foster empathy and responsiveness to patients’ problems as they experience them, not only as professionals define them."
Article |
Thread
The Ocular Surface
Heightened visual light sensitivity discomfort measured by the ocular photosensitivity analyzer is associated with chronic ocular pain — Karakoleva et al.
"our group developed the Ocular Photosensitivity Analyzer (OPA), a validated, automated system designed to quantify visual photosensitivity discomfort thresholds" "fibromyalgia and chronic fatigue emerged as the most significant predictors, suggesting that photoallodynia presence may be more pronounced in individuals with broader nociplastic phenotypes."
Article |
Thread
Long Covid research
Frontiers in Neurology
Prevalence and severity of neurologic symptoms in Long-COVID and the role of pre-existing conditions, hospitalization, and mental health — Huff, Nath, Walitt et al.
"these data do not support the idea of neurological vulnerability. Neither self-reported pre-existing neurological nor psychiatric conditions have a statistically significant impact on the development of neurological symptoms after SARS-CoV-2." "With increasing elapsed time from infection, the neurological symptoms resemble those of fibromyalgia and ME/CFS"
Article |
Thread
Frontiers in Immunology
Dysregulated monocyte compartment in PACS patients — Kronstein-Wiedemann et al.
"Our findings indicate that intermediate monocytes and CD56+ monocytes are expanded in PACS patients. These monocyte compartment perturbations were also found in PACS patients with a disease duration greater than two years, suggesting a persistent and long-term dysregulation of the monocyte subsets."
Article |
Thread
European Journal of Nuclear Medicine and Molecular Imaging
[68Ga]FAPI PET/CT reveals increased pulmonary fibroblast activation protein expression in long COVID patients after ICU discharge — van Leer et al.
"More than 2 years after hospital discharge, markedly increased pulmonary [68 Ga]FAPI uptake was observed in PASC" "In addition, we found increased FAP expression in muscle tissue of PASC patients." "To our knowledge this is the first time that increased muscle FAP expression in PASC patients has been shown."
Article |
Thread
Viruses
SARS-CoV-2 (MA10) Infection Aggravates Cerebrovascular Pathology in Endothelial Nitric Oxide Synthase-Deficient Mice — Ismael et al.
Mouse study. "MA10 viral RNA was not detected in the infected brain, implying that the neuropathological events are independent of brain viral invasion" "fibrin-rich intravascular microthrombi were detected in the cerebral cortex of eNOS-deficient mice, confirming the pathological role of NO deficiency in hypercoagulopathy state independent of infection"
Article |
Thread
Journal of Medical Economics
Quantifying all-cause healthcare resource utilization and costs of children with mild-to-moderate long COVID in France — Jingyan Yang et al.
"In the present study of 27,573 children diagnosed with COVID-19, 14.1% and 17.4% had long COVID per the WHO and NICE definitions, respectively. Evaluation of the all-cause HCRU and costs of these children demonstrated that pediatric long COVID managed in the community imposes a non-neglectable clinical and economic burden to the French healthcare system"
Article |
Thread
...........
S4ME social media:
Forum,
Mastodon,
Bluesky